Visit Blaskovich group webpage

Dr Peta Harvey was appointed to the NMR Facility in January 2009. Dr Harvey is an instrumental specialist with more than 20 years of experience in the use of NMR techniques as well as the operation, systems management, training and supervision of spectrometer usage. Having applied multinuclear NMR methods during her PhD studies in mechanistic organic chemistry, she has diversified her interests from liver dysfunction and altered drug metabolism in the cirrhotic and aged liver (Canberra Clinical School of University of Sydney) to structural studies of muscle related proteins (Australian National University). More recently whilst at IMB, her particular expertise has extended to the structural and functional characterization of peptides and small proteins with complex cross-linked topologies and the use of such bioactive peptides in drug design.

Dr Harvey has contributed to numerous multi-disciplinary collaborative research projects. She is the co-author of over 45 papers in high quality international peer-reviewed journals.

Alun has more than 28 years of experience in biological mass spectrometry in both academia and industry in the UK, Canada and USA. During this time, he has developed HPLC-mass spectrometry interfaces, methods of analysis for natural products, drug and pesticide analysis, peptide and protein analysis.

Angelika Christ is Facility Manager of the IMB Sequencing Facility, where she leads a team of sequencing and bioinformatition specialists, producing high-quality sequencing libraries and next-generation sequencing data.

Angelika and her team help find researchers the best approach to their sequencing projects — ranging from agriculture, to drug development and medical research — and ensure the best outcomes.

Angelika has 13 years of commercial and research laboratory experience. She has worked in the field of next-generation sequencing since 2010 on various technology platforms and applications.

Angelika holds a Dipl.-Ing (FH) (equivalent to masters degree) in Biochemistry from the Mannheim University of Applied Sciences in Germany and a brings experience in organic chemistry and peptide chemistry as well as cell culture and assay development to her work at the IMB Sequencing Facility.

View Angelika's publications via PubMed

  Cellular reprogramming and ageing group

Highlights

Professor Grant Montgomery uses genetic approaches to discover critical genes and pathways increasing risk for reproductive disorders. He applies state of the art genomic techniques to identify risk factors and understand how these genetic differences regulate gene expression and epigenetics to alter disease risk. The goal is to understand disease biology and help develop better methods for diagnosis and treatment.

A major focus is women’s health and the pathogenesis of endometriosis. Together with colleagues in Brisbane, he led a recent large international study on genetic risk factors for endometriosis which confirmed 14 regions of the genome are associated with the disease, including 5 novel regions. His research is now moving to functional studies to identify the target genes in each region and determine how changes in the regulation of these genes contribute to disease. Professor Montgomery has published the first examples of likely target genes for two regions.

He is also using genomic approaches to help understand environmental risk factors for this disease. Environmental risk factors may leave epigenetic signals on DNA that are associated with disease and he is part of an international study on global methylation analysis in endometriosis.

Video

Connect